On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Cyclacel Limited's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€115k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- OCTIPSPartner
Ovarian Cancer Therapy – Innovative Models Prolong Survival
FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗
€115ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Katholieke Universiteit LeuvenBelgium · 1 shared project
- Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
- Imperial College of Science Technology and MedicineUnited Kingdom · 1 shared project
- The University of EdinburghUnited Kingdom · 1 shared project
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 1 shared project
- Charite - Universitaetsmedizin BerlinGermany · 1 shared project
- Medizinische Universitaet WienAustria · 1 shared project
- Emergentec Biodevelopment GmbHAustria · 1 shared project
- Innovo Mimetics LimitedIsrael · 1 shared project
- Alcedis GmbHGermany · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- mortality
- oncology
- surgery
- transition metals
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.